Large-scale testing (Phase 3)Study completedNCT00478660
What this trial is testing
An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)
Who this might be right for
Ankylosing Spondylitis
Abbott 1,250